VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Public ClinicalTrials.gov record NCT00063713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find out whether treatment with VELCADE will increase the time it takes for lymphoma to get worse.
Study identification
- NCT ID
- NCT00063713
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 152 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2003 (Type not available)
- Primary completion
- Dec 2005 (Actual)
- Completion
- Not listed
- Last update posted
- Feb 11, 2008
Started 2003
United States locations
- U.S. sites
- 35
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| Alta Bates Medical Center | Berkeley | California | 94704 | — |
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010-3000 | — |
| Loma Linda Cancer Research Institute | Loma Linda | California | 92354 | — |
| UCLA School of Medicine | Los Angeles | California | 90095 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| University of Colorado Cancer | Denver | Colorado | 80262 | — |
| Georgetown University Medical Center Lombardi Cancer Center | Washington D.C. | District of Columbia | 20007 | — |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | 33612 | — |
| The Emory Clinic | Atlanta | Georgia | 30322 | — |
| The Rush Cancer Center | Chicago | Illinois | 60612 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Indiana University Cancer Center | Indianapolis | Indiana | 46202 | — |
| University of Iowa Hospital Division | Iowa City | Iowa | 52242 | — |
| North Memorial Hospital | Robbinsdale | Minnesota | 55422 | — |
| Onc/Hem Associates of Kansas City | Kansas City | Missouri | 64111 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| St Lukes-Roosevelt Hospital | New York | New York | 10019 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | — |
| New York Hospital Cornell Medical Center | New York | New York | 10021 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Wake Forest, University health Sciences/Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157 | — |
| Cancer Care Associates | Oklahoma City | Oklahoma | 73112 | — |
| Cancer Care Associates | Tulsa | Oklahoma | 74136 | — |
| Oregon Health Science University | Portland | Oregon | 97239 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| Sarah Cannon Cancer Center | Nashville | Tennessee | — | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| University Hospital-Madison Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00063713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2008 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00063713 live on ClinicalTrials.gov.